Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Search results

36 items matching your search terms.
Advanced cancer patient preferences for receiving molecular profiling results
Best, M.; Butow, P.; Jacobs, C.; Juraskova, I.; Savard, J.; Meiser, B.; Goldstein, D.; Ballinger, M.; Bartley, N.; Napier, C.; Davies, G.; Thomas, D.; Tucker, K.; Schlub, T.; Newson, A. J.; PiGeOn Project, .
PSYCHO-ONCOLOGY 29 (10) :1533-1539, 2020 10.1002/pon.5446
Cancer patients' views and understanding of genome sequencing: a qualitative study
Bartley, N.; Best, M.; Jacobs, C.; Juraskova, I.; Newson, A. J.; Savard, J.; Meiser, B.; Ballinger, M. L.; Thomas, D. M.; Biesecker, B.; Butow, P.
JOURNAL OF MEDICAL GENETICS 57 (10) :671-676, 2020 10.1136/jmedgenet-2019-106410
Advanced cancer patient wnowledge of and attitudes towards tumor molecular profiling
Davies, G.; Butow, P.; Napier, C. E.; Bartley, N.; Juraskova, I.; Meiser, B.; Ballinger, M. L.; Thomas, D. M.; Schlub, T. E.; Best, M. C.; members of the PiGeOn, Project.
Translational Oncology 13 (9) :100799, 2020 10.1016/j.tranon.2020.100799
Assessment of the value of tumor variation profiling perceived by patients with cancer
Butow, P.; Davies, G.; Napier, C. E.; Schlub, T.; Best, M. C.; Bartley, N.; Juraskova, I.; Meiser, B.; Ballinger, M. L.; Biesecker, B.; Goldstein, D.; Thomas, D. M.; PiGeOn, Project
JAMA Network Open 3 (5) :e204721, 2020 10.1001/jamanetworkopen.2020.4721
Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma
Mirabello, L.; Zhu, B.; Koster, R.; Karlins, E.; Dean, M.; Yeager, M.; Gianferante, M.; Spector, L. G.; Morton, L. M.; Karyadi, D.; Robison, L. L.; Armstrong, G. T.; Bhatia, S.; Song, L.; Pankratz, N.; Pinheiro, M.; Gastier-Foster, J. M.; Gorlick, R.; de Toledo, S. R. C.; Petrilli, A. S.; Patino-Garcia, A.; Lecanda, F.; Gutierrez-Jimeno, M.; Serra, M.; Hattinger, C.; Picci, P.; Scotlandi, K.; Flanagan, A. M.; Tirabosco, R.; Amary, M. F.; Kurucu, N.; Ilhan, I. E.; Ballinger, M. L.; Thomas, D. M.; Barkauskas, D. A.; Mejia-Baltodano, G.; Valverde, P.; Hicks, B. D.; Zhu, B.; Wang, M.; Hutchinson, A. A.; Tucker, M.; Sampson, J.; Landi, M. T.; Freedman, N. D.; Gapstur, S.; Carter, B.; Hoover, R. N.; Chanock, S. J.; Savage, S. A.
JAMA Oncology 6 (5) :724-734, 2020 10.1001/jamaoncol.2020.0197
Who should access germline genome sequencing? A mixed methods study of patient views
Best, M. C.; Butow, P.; Jacobs, C.; Savard, J.; Biesecker, B.; Ballinger, M. L.; Bartley, N.; Davies, G.; Napier, C. E.; Smit, A. K.; Thomas, D. M.; Newson, A. J.; Members of the PiGeOn Project, .
CLINICAL GENETICS 97 (2) :329-337, 2020 10.1111/cge.13664
Penetrance of different cancer types in families with Li-Fraumeni syndrome: A validation study using multicenter cohort.
Shin, S. J.; Dodd-Eaton, E. B.; Peng, G.; Bojadzieva, J.; Chen, J.; Amos, C. I.; Frone, M. N.; Khincha, P. P.; Mai, P. L.; Savage, S. A.; Ballinger, M. L.; Thomas, D. M.; Yuan, Y.; Strong, L. C.; Wang, W.
CANCER RESEARCH 80 (2) :354-360, 2020 10.1158/0008-5472.CAN-19-0728
Patient perspectives on molecular tumor profiling: "Why wouldn't you?"
Best, M. C.; Bartley, N.; Jacobs, C.; Juraskova, I.; Goldstein, D.; Newson, A. J.; Savard, J.; Meiser, B.; Ballinger, M.; Napier, C.; Thomas, D.; Biesecker, B.; Butow, P.
BMC Cancer 19 (1) :753, 2019 10.1186/s12885-019-5920-x
A quantitative model to predict pathogenicity of missense variants in the TP53 gene
Fortuno, C.; Cipponi, A.; Ballinger, M. L.; Tavtigian, S. V.; Olivier, M.; Ruparel, V.; Haupt, Y.; Haupt, S.; Study, I. S. K.; Tucker, K.; Spurdle, A. B.; Thomas, D. M.; James, P. A.
HUMAN MUTATION 40 (6) :788-800, 2019 10.1002/humu.23739
Therapeutic implications of germline genetic findings in cancer
Thavaneswaran, S.; Rath, E.; Tucker, K.; Joshua, A. M.; Hess, D.; Pinese, M.; Ballinger, M. L.; Thomas, D. M.
Nature Reviews Clinical Oncology 16 (6) :386-396, 2019 10.1038/s41571-019-0179-3
OpenAccess publication Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts
Jones, R. M.; Melton, P. E.; Pinese, M.; Rea, A. J.; Ingley, E.; Ballinger, M. L.; Wood, D. J.; Thomas, D. M.; Moses, E. K.
BMC Medical Genetics 20 (1) :69, 2019 10.1186/s12881-019-0808-9
Diagnosis of fusion genes using targeted RNA sequencing
Heyer, E. E.; Deveson, I. W.; Wooi, D.; Selinger, C. I.; Lyons, R. J.; Hayes, V. M.; O'Toole, S. A.; Ballinger, M. L.; Gill, D.; Thomas, D. M.; Mercer, T. R.; Blackburn, J.
Nature Communications 10 (1) :1388, 2019 10.1038/s41467-019-09374-9
Translating genomic risk into an early detection strategy for sarcoma
Ballinger, M. L.; Pinese, M.; Thomas, D. M.
GENES CHROMOSOMES & CANCER 58 :130-136, 2019 10.1002/gcc.22697
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers
Thavaneswaran, S.; Sebastian, L.; Ballinger, M.; Best, M.; Hess, D.; Lee, C. K.; Sjoquist, K. M.; Hague, W. E.; Butow, P. N.; Simes, R. J.; Thomas, D.
MEDICAL JOURNAL OF AUSTRALIA 209 (8) :354-355, 2018
Development and pilot testing of a decision aid for genomic research participants notified of clinically actionable research findings for cancer risk
Willis, A. M.; Smith, S. K.; Meiser, B.; Ballinger, M. L.; Thomas, D. M.; Tattersall, M.; Young, M. A.
Journal of Genetic Counseling 27 (5) :1055-1066, 2018 10.1007/s10897-018-0223-y